JNOV, New Trial Denied In $2.1M Aredia / Zometa Jaw Injury Verdict

JNOV, New Trial Denied In $2.1M Aredia / Zometa Jaw Injury Verdict

LOS ANGELES - A California federal judge on Dec. 30 denied judgment as a matter of law (JNOV) or a new trial for Novartis Pharmaceuticals Corp. in an Aredia/Zometa jaw injury trial that resulted in a $2.16 million verdict in April (Adriann Georges v. Novartis Pharmaceuticals Corp., et al., No. 06-5207, C.D. Calif.).

Find full version on lexis Advance®
Access this news story on lexis.com®